United States
Germany
Japan
United Kingdom
China
Recombinant Anti-VEGF (Clone Bevacizumab)
| Applications | Bl, ELISA, FC, IP, WB |
| Reactivities | Human |
Primary Antibodies
Recombinant Anti-VEGF (Clone Bevacizumab)
| Applications | Bl, ELISA, FC, IP, WB |
| Reactivities | Human |
CNY 6,881.00
6周
Recombinant Anti-Integrin alpha 4 (Clone Natalizumab)
| Applications | Bl, FC |
| Reactivities | Human |
Recombinant Anti-VEGF (Clone Bevacizumab)
| Applications | Bl, ELISA, FC, IP, WB |
| Reactivities | Human |
CD33 monoclonal antibody (gemtuzumab ozogamicin biosimilar)
| Applications | FC |
| Reactivities | Human |
CD138 monoclonal antibody (indatuximab ravtansine biosimilar)
| Applications | FC |
| Reactivities | Human |
Recombinant Anti-CD4 (Clone CE9.1 (Clenoliximab))
| Applications | Bl, ELISA, FC, IHC |
| Reactivities | Human, Chimpanzee |
Recombinant Anti-TNF alpha (Clone D2E7 (Adalimumab))
| Applications | Bl, ELISA, IF, IHC |
| Reactivities | Human |
Recombinant Anti-TNF alpha (Clone D2E7 (Adalimumab))
| Applications | Bl, ELISA, IF, IHC |
| Reactivities | Human |
Recombinant Anti-TNF alpha (Clone CDP 571 (Humicade))
| Applications | ELISA |
| Reactivities | Human |
Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))
| Applications | ELISA, FC, IHC |
| Reactivities | Human |
Recombinant Anti-CD41 (Clone 7E3 (Abciximab))
| Applications | Bl, FC |
| Reactivities | Human |
Recombinant Anti-Integrin alpha 4 (Clone Natalizumab)
| Applications | Bl, FC |
| Reactivities | Human |
Recombinant Anti-TNF alpha (Clone CDP 571 (Humicade))
| Applications | ELISA |
| Reactivities | Human |
Recombinant Anti-CD20 (Clone 10F381 (rituximab))
| Applications | FC |
| Reactivities | Human, Monkey |
